Syndax Pharmaceuticals SNDX reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Syndax Pharmaceuticals beat estimated earnings by 546.43%, reporting an EPS of $1.81 versus an estimate of $0.28.
Revenue was up $126.20 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.17 which was followed by a 2.29% increase in the share price the next day.
Here's a look at Syndax Pharmaceuticals's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.23 | -0.71 | -0.65 | -0.49 |
EPS Actual | -0.40 | -0.44 | -0.54 | -0.44 |
Revenue Estimate | 29.35M | 220.00K | 220.00K | 200.00K |
Revenue Actual | 12.38M | 379.00K | 379.00K | 380.00K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.